Bharat Biotech launches conjugate typhoid vaccine

Bharat Biotech launched the world’s first clinically proven conjugate Typhoid vaccine ‘Typbar-TCV’, which offers long-term protection.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news